Bioxytran Inc
(BIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 2,223 | 3,800 | 2,437 | 4,214 | 1,269 |
| Operating Income | -2,223 | -3,800 | -2,437 | -4,214 | -1,269 |
| Interest Expense | 93 | 193 | 207 | 237 | 1,015 |
| Other Income | -64 | -569 | -23 | -77 | -259 |
| Pre-tax Income | -2,380 | -4,563 | -2,667 | -4,528 | -2,543 |
| Net Income Continuous | -2,380 | -4,563 | -2,667 | -4,528 | -2,543 |
| Minority Interests | -13 | -90 | -193 | -496 | -62 |
| Net Income | $-2,367 | $-4,473 | $-2,473 | $-4,032 | $-2,481 |
| EPS Basic Total Ops | -0.02 | -0.03 | -0.02 | -0.04 | -0.03 |
| EPS Basic Continuous Ops | -0.02 | -0.03 | -0.02 | -0.04 | -0.03 |
| EPS Diluted Total Ops | -0.02 | -0.03 | -0.02 | -0.04 | -0.03 |
| EPS Diluted Continuous Ops | -0.02 | -0.03 | -0.02 | -0.04 | -0.03 |
| EPS Diluted Before Non-Recurring Items | -0.02 | -0.03 | N/A | -0.04 | -0.03 |
| EBITDA(a) | $-1,537 | $-3,443 | $-2,114 | $-4,137 | $-1,010 |